UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

K2LOB

FRBNPP06PN51

Real-time Euronext Paris 12:44:14 17/05/2024 BST
1.225 EUR +8.89% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month+39.75%
Date Price Change
17/05/24 1.225 +8.89%
16/05/24 1.125 -8.16%
15/05/24 1.225 -0.81%
14/05/24 1.235 +6.01%
13/05/24 1.165 +4.48%

Real-time Euronext Paris

Last update May 17, 2024 at 12:44 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
K2LOB
ISINFRBNPP06PN51
Date issued 17/04/2024
Strike 82.29 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.255
Lowest since issue 0.27
Spread 0.01
Spread %0.82%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.4 USD
Average target price
108.5 USD
Spread / Average Target
+5.98%
Consensus
  1. Stock Market
  2. Certificates
  3. K2LOB Certificat